000 | 01954 a2200565 4500 | ||
---|---|---|---|
005 | 20250514212801.0 | ||
264 | 0 | _c20050302 | |
008 | 200503s 0 0 eng d | ||
022 | _a0009-9104 | ||
024 | 7 |
_a10.1111/j.1365-2249.2005.02654.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNozaki, Y | |
245 | 0 | 0 |
_aThe beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice. _h[electronic resource] |
260 |
_bClinical and experimental immunology _cJan 2005 |
||
300 |
_a74-83 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Antinuclear _xblood |
650 | 0 | 4 |
_aBody Weight _xdrug effects |
650 | 0 | 4 |
_aChemokine CCL2 _ximmunology |
650 | 0 | 4 |
_aCytokines _xblood |
650 | 0 | 4 |
_aDNA _ximmunology |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
650 | 0 | 4 |
_aImmunoglobulin G _xanalysis |
650 | 0 | 4 |
_aImmunohistochemistry _xmethods |
650 | 0 | 4 |
_aKeratolytic Agents _xtherapeutic use |
650 | 0 | 4 |
_aKidney _ximmunology |
650 | 0 | 4 |
_aLupus Nephritis _xblood |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred NZB |
650 | 0 | 4 |
_aNitric Oxide Synthase _ximmunology |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 |
_aPrednisolone _xtherapeutic use |
650 | 0 | 4 |
_aProteinuria _xdrug therapy |
650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
650 | 0 | 4 |
_aSpleen _xdrug effects |
650 | 0 | 4 |
_aTretinoin _xtherapeutic use |
700 | 1 | _aYamagata, T | |
700 | 1 | _aYoo, B-S | |
700 | 1 | _aSugiyama, M | |
700 | 1 | _aIkoma, S | |
700 | 1 | _aKinoshita, K | |
700 | 1 | _aFunauchi, M | |
700 | 1 | _aKanamaru, A | |
773 | 0 |
_tClinical and experimental immunology _gvol. 139 _gno. 1 _gp. 74-83 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2249.2005.02654.x _zAvailable from publisher's website |
999 |
_c15288640 _d15288640 |